OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Accelerating Access to Critical Therapies for Als Act

Floor Speech

Date: Dec. 8, 2021
Location: Washington, DC

BREAK IN TRANSCRIPT

Mr. CURTIS. Mr. Speaker, I rise to share my support for expanding access for individuals to investigative drugs because I am concerned that we are not moving swiftly enough in order to prevent diagnosis, mitigate, treat, or cure ALS.

This is very personal to me, it is very personal to the committee. It hits extremely close to home for so many of us who have lost friends, and have seen good friends and neighbors struggle with their families with this difficult disease.

I had the opportunity to speak about this earlier today in the Energy and Commerce Committee hearing on biomedical innovation. We are not moving fast enough and we have more work to do.

Mr. Speaker, I applaud this Accelerating Access to Critical Therapies for ALS Act for working to create and further develop public-private partnerships and to prevent policies from being enacted that impede private sector investments and advancements.

Mr. Speaker, I urge my colleagues to support this bill.

BREAK IN TRANSCRIPT


Source
arrow_upward